A critical discovery in cancer investigation is arising with the use of VHH fragments to reactivate mutated p53. This crucial cancer inhibitor protein is frequently disabled in many types of tumors, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research